Search

Pneumococcal vaccine sees hospital admissions for deadly pneumonia slashed by half

Thousands of children born in Papua New Guinea (PNG) no longer face a future cut short by severe pneumonia, thanks to the introduction of pneumococcal vaccination as part of the country’s National Immunisation Program.

Major grant empowers community voices to drive reduction in skin infections

Aboriginal community members throughout the Kimberley will take a lead role in driving healthy skin messages within their own communities thanks to a major funding boost to The Kids Research Institute Australia’s SToP Trial.

Telethon donations fund early flu protection for bubs

Babies worldwide could have access to life-saving influenza vaccinations from just eight weeks of age thanks to researchers at The Kids Research Institute Australia and the generous support of the Telethon community.

Childhood influenza vaccination rates improves with better access

More children across Australia are being vaccinated against the flu since funding was expanded and access widened under the National Immunisation Program

Perth’s Aboriginal babies show first signs of ear disease at just eight weeks

The Kids Research Institute Australia researchers have found close to 40 per cent of Aboriginal babies begin to develop middle ear infections between two and four months of age in a first of its kind study in metropolitan Perth.

The Kids researchers honoured at Premier’s Science Awards

Congratulations to Telethon Kids Institute researcher Dr Chris Brennan-Jones who was named Woodside Early Career Scientist of the Year at last night’s 2020 Premier’s Science Awards.

Pneumococcal and Meningococcal

Update on pneumococcal and meningococcal vaccine research

Child health a focus in national research grants

The Kids Research Institute Australia researchers have been awarded more than $8 million in prestigious project grants from the NHMRC.

Speech Pathology Perth

Evidence-based paediatric speech therapy in Perth, tailored to each child’s needs.

The use of psychotropic medications in autistic individuals (21 years and younger) in Western Australia: A preliminary investigation

Prescriptions and use of medications to treat mental health conditions in young autistic populations are inconsistent worldwide. This makes it hard to compare findings from international studies to the Australian autistic population, where there are limited relevant studies. Apart from risperidone, there are no other medications specified for direct use in autistic persons. This study aims to gain initial broad understanding of the use of medications, commonly prescribed for mental health conditions, specifically by autistics under the age of 21 years.